Based on existing evidence, we believe so. Here’s why:
UVC light has been used extensively for more than 40 years in disinfecting drinking water, waste water, air, pharmaceutical products, and surfaces against a whole suite of human pathogens (Fluence UV Dose Required review IUVA). All bacteria and viruses tested to date (many hundreds over the years, including other coronaviruses) respond to UV disinfection. Some organisms are more susceptible to UVC disinfection than others, but all tested so far do respond at the appropriate doses.
- COVID-19 infections can be caused by contact with contaminated surfaces and then touching facial areas (less common than person-to-person, but still an issue)[vi]. Minimizing this risk is key because COVID-19 virus can live on plastic and steel surfaces for up to 3 days[vii]. Normal cleaning and disinfection may leave behind some residual contamination, which UVC can treat suggesting that a multiple disinfectant approach is prudent. UVC has been shown to achieve a high level of inactivation of a near-relative of COVID-19’s virus (i.e., SARS-CoV-1, tested with adequate dose of 254nm UV while suspended in liquid)[viii]. IUVA believes similar results can be expected when treating COVID-19’s virus, SARS-CoV-2. However, the key is applying UVC in such a way that it can effectively reach any remaining viruses on those surfaces.
- IUVA also concurs with CDC guidance to hospitals that the germicidal effectiveness of UVC is influenced by the UVC absorbing properties of the suspension, the surface or aerosol that the organism is in; by the type or action spectra of the microorganism; and by a variety of design and operating factors that impact the delivered UV dose to the microorganism (https://www.cdc.gov/infectioncontrol/guidelines/disinfection).
- IUVA recognizes that in the cases where the UVC light cannot reach a particular pathogen, that pathogen will not be disinfected. However in general, reducing the total number of pathogens reduces the risk of transmission. The total pathogenic load can be reduced substantially by applying UV to the many surfaces that are readily exposed, as a secondary barrier to cleaning, especially in hurried conditions. This would be a relatively straight-forward matter of illuminating the relevant surfaces with UVC light, for example the air and surfaces around/in rooms and personal protective equipment.
- UV light, specifically between 200-280nm[i] (UVC or the germicidal range), inactivates (aka, ‘kills’) at least two other coronaviruses that are near-relatives of the COVID-19 virus: 1) SARS-CoV-1[ii] and 2) MERS-CoV[iii] [iv] [v]. An important caveat is this inactivation has been demonstrated under controlled conditions in the laboratory. The effectiveness of UV light in practice depends on factors such the exposure time and the ability of the UV light to reach the viruses in water, air, and in the folds and crevices of materials and surfaces.
[i] “Miscellaneous Inactivating Agents - Guideline for Disinfection and Sterilization in Healthcare Facilities (2008);” Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Healthcare Quality Promotion (DHQP) (https://www.cdc.gov/infectioncontrol/guidelines/disinfection/disinfection-methods/miscellaneous.html)
[vi] “Preventing the Spread of Coronavirus Disease 2019 in Homes and Residential Communities”; National Center for Immunization and Respiratory Diseases (NCIRD), Div. of Viral Diseases (https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-prevent-spread.html)
[vii] “New coronavirus stable for hours on surfaces”; CDC (extracted from N van Doremalen, et al. Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1. The New England Journal of Medicine. DOI: 10.1056/NEJMc2004973 (2020) (https://www.nih.gov/news-events/news-releases/new-coronavirus-stable-hours-surfaces).
[viii] “Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents;” Kariwa H et al. Dermatology 2006;212 (Suppl 1): 119 (https://www.ncbi.nlm.nih.gov/pubmed/16490989)